Chartwell Pharmaceuticals
Charlie Piehler has extensive experience in maintenance management across various industries, including pharmaceuticals, lighting, and manufacturing. Currently serving as the Production Maintenance Manager at Chartwell Pharmaceuticals since June 2018, Charlie oversees production maintenance operations. Previous roles include Facilities Manager at RAB Lighting, where responsibilities encompassed maintenance for company-owned properties and a fleet of material handling equipment. Charlie also held positions in manufacturing maintenance management at Dale & Thomas Popcorn, facility/equipment maintenance management at Marcal Manufacturing, and various roles in television production settings as a Set/Stage Medic. Additional experience includes management roles at Chromalloy and Rockline Industries, as well as long-standing service at Barr Laboratories as Maintenance Supervisor and early experience as a Field Service Technician at Vernitron Medical Products.
Chartwell Pharmaceuticals
CHARTING A COURSE TO WELLNESS Chartwell Pharmaceuticals is a US-based development, manufacturing and commercial organization located in Congers, New York. Our facility produces prescription pharmaceutical products with a commitment to superior quality, compliance, and customer service. Chartwell Pharmaceuticals has a long history as a preferred manufacturing partner for prescription solid dosage products in tablet, capsule, and powders forms. Recent expansion now adds capabilities for suspensions, enemas and liquids manufacturing - including Unit Dose cups. Our rooms are large, our ceilings are high, and facilities are pristine. Our exceptional hands-on leadership team and technical staff bring decades of pharmaceutical industry experience in manufacturing and analytical services for development, scale-up, transferring, changing, launching, and supplying products. Under our own Chartwell labels, our mission is to provide a consistent, timely and quality product supply to our pharmacy customers and their patients. Our current portfolio stands at over 250 Orange Book listed ANDAs and NDAs, with an aggressive asset development and acquisition program in place. Supported by Chartwell Labs, our Formulations and Analytical team, we are quickly continuing to broaden our line through commercial Chartwell-labeled branding. Chartwell Pharmaceuticals is proud to be manufacturing "Made in the USA" products.